Exane Derivatives Chemours CO Transaction History
Exane Derivatives
- $157 Million
- Q2 2022
A detailed history of Exane Derivatives transactions in Chemours CO stock. As of the latest transaction made, Exane Derivatives holds 52 shares of CC stock, worth $1,134. This represents 0.0% of its overall portfolio holdings.
Number of Shares
52
Previous 52
-0.0%
Holding current value
$1,134
Previous $1,000
-0.0%
% of portfolio
0.0%
Previous 0.0%
Shares
7 transactions
Others Institutions Holding CC
# of Institutions
484Shares Held
101MCall Options Held
806KPut Options Held
1.1M-
Black Rock Inc. New York, NY16.3MShares$355 Million0.01% of portfolio
-
Vanguard Group Inc Valley Forge, PA15.1MShares$330 Million0.01% of portfolio
-
Marshall Wace, LLP London, X07.12MShares$155 Million0.19% of portfolio
-
State Street Corp Boston, MA4.55MShares$99.2 Million0.0% of portfolio
-
Ameriprise Financial Inc Minneapolis, MN3.53MShares$77.1 Million0.02% of portfolio
About Chemours Co
- Ticker CC
- Exchange NYSE
- Sector Basic Materials
- Industry Specialty Chemicals
- Shares Outstandng 150,918,000
- Market Cap $3.29B
- Description
- The Chemours Company provides performance chemicals in North America, the Asia Pacific, Europe, the Middle East, Africa, and Latin America. It operates through four segments: Titanium Technologies, Thermal & Specialized Solutions, Advanced Performance Materials, and Chemical Solutions. The Titanium Technologies segment provides TiO2 pigment ...